Skip to main content
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: Virology. 2020 Jul 22;548:182–191. doi: 10.1016/j.virol.2020.07.009

Figure 4. gB-specific mAbs mediate negligible NK activation when compared to polyclonal CMV-specific antibody preparation (Cytogam).

Figure 4.

gB-specific mAbs were screened for mediation of NK cell (A) CD107a degranulation and (B) CD16 downregulation (DRI) as measures of antibody-mediated NK cell activation. mAbs were compared against polyclonal CMV-specific antibody preparation (Cytogam) and monoclonal RSV-specific antibody preparation (Synagis). Data are presented as mAb specific response against AD169r-GFP infected ARPE19 cells minus mock infected negative control cells.